Monoclonal antibodies - Gene Cloning - Biochemical Conjugation
How we got $426K
Based on typical figures for its industry (2022 Economic Census), not its own records.
What we know
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| Monoclonal antibodies - Gene Cloning - Biochemical Conjugation this business | $1.3M | — |
| Best Exterminators Oklahoma City | $958K | 0.1 mi |
| Synaptacode Oklahoma City | $1.3M | 0.2 mi |
| Executive Shorthand Reporters Of Ok Oklahoma City | $948K | 0.2 mi |
| Legalese Reporting Service Oklahoma City | $948K | 0.2 mi |
| Skylne Development Inc. - Real Estate Investments Oklahoma City | $1.3M | 0.2 mi |
| Globelink Security $12.99 Alarm Monitoring Llc Oklahoma City | $1.6M | 0.3 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $426K |
| Multiple for this size and industry | 2.5× |
| Value range | $106K – $763K |
This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Administrative and support and waste management and remediation services businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (14%). Treat these as a rough guide.
| Revenue range | $391K – $1.9M |
| EBITDA range | $53K – $254K |
| Industry (NAICS) | Administrative and support and waste management and remediation services (56) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology
About Monoclonal antibodies - Gene Cloning - Biochemical Conjugation
Monoclonal antibodies - Gene Cloning - Biochemical Conjugation is an administrative and support and waste management and remediation services company in Oklahoma City, Oklahoma. Its estimated annual revenue is about $1.3M, with roughly $171K of EBITDA. Its estimated business value is $426K (likely range $106K–$763K).
Common questions
- Who owns Monoclonal antibodies - Gene Cloning - Biochemical Conjugation?
- The owner of Monoclonal antibodies - Gene Cloning - Biochemical Conjugation isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does Monoclonal antibodies - Gene Cloning - Biochemical Conjugation make?
- SeeBITDA estimates Monoclonal antibodies - Gene Cloning - Biochemical Conjugation's annual revenue at about $1.3M (likely between $391K and $1.9M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Monoclonal antibodies - Gene Cloning - Biochemical Conjugation worth?
- About $426K, roughly 2.5× its estimated EBITDA of $171K, typical for a administrative and support and waste management and remediation services company its size. Likely range: $106K–$763K.